Haig Aghajanian: The End of My Chapter with Capstan
Haig Aghajanian, Former Head of Research at Capstan Therapeutics, shared a post on LinkedIn:
”Today marks the end of my chapter with Capstan. What started off as a dream almost a decade ago has become a dream come true for a scientist trying to bring innovative technology to the patients who need it. I am eternally grateful to everyone who has made this possible by seeing the vision and buying in so wholeheartedly.
I especially want to thank my brilliant co-founders, stellar Capstan leadership past and present, all of the dedicated Capstaneers past and present, Penn PCI, our supportive investors, and everyone who has supported us along the way, particularly the families (I couldn’t do any of this without my incredible wife and family).
I am excited to see where this technology goes for patients and am so thankful to AbbVie for taking the baton and running with this amazing platform. As for me, I am more dedicated than ever to try and deliver life-changing science to those in need.
Thank you.”
More posts featuring Haig Aghajanian on OncoDaily.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023